181 related articles for article (PubMed ID: 19067140)
21. Effects of fulminant hepatic encephalopathy on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na(+),K (+))- and Mg (2+)-ATPase: comparison of the enzymes' response to in vitro treatment with ammonia.
Zarros A; Theocharis S; Skandali N; Tsakiris S
Metab Brain Dis; 2008 Sep; 23(3):255-64. PubMed ID: 18665440
[TBL] [Abstract][Full Text] [Related]
22. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic neurotransmission.
Norenberg MD; Huo Z; Neary JT; Roig-Cantesano A
Glia; 1997 Sep; 21(1):124-33. PubMed ID: 9298855
[TBL] [Abstract][Full Text] [Related]
23. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
[TBL] [Abstract][Full Text] [Related]
24. Brain metabolism in encephalopathy caused by hyperammonemia.
Hawkins RA; Mans AM
Adv Exp Med Biol; 1994; 368():11-21. PubMed ID: 7741001
[No Abstract] [Full Text] [Related]
25. Identifying the direct effects of ammonia on the brain.
Bosoi CR; Rose CF
Metab Brain Dis; 2009 Mar; 24(1):95-102. PubMed ID: 19104924
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy.
Leke R; Bak LK; Iversen P; Sørensen M; Keiding S; Vilstrup H; Ott P; Portela LV; Schousboe A; Waagepetersen HS
J Neurochem; 2011 Jun; 117(5):824-32. PubMed ID: 21395584
[TBL] [Abstract][Full Text] [Related]
27. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis.
Ahl B; Weissenborn K; van den Hoff J; Fischer-Wasels D; Köstler H; Hecker H; Burchert W
Hepatology; 2004 Jul; 40(1):73-9. PubMed ID: 15239088
[TBL] [Abstract][Full Text] [Related]
28. No oxygen delivery limitation in hepatic encephalopathy.
Gjedde A; Keiding S; Vilstrup H; Iversen P
Metab Brain Dis; 2010 Mar; 25(1):57-63. PubMed ID: 20182779
[TBL] [Abstract][Full Text] [Related]
29. Functional imaging of the brain in patients with liver cirrhosis.
Weissenborn K; Bokemeyer M; Ahl B; Fischer-Wasels D; Giewekemeyer K; van den Hoff J; Köstler H; Berding G
Metab Brain Dis; 2004 Dec; 19(3-4):269-80. PubMed ID: 15554422
[TBL] [Abstract][Full Text] [Related]
30. [Positron emission tomography (PET) before and after treatment of hyperammonemia in a patient with decompensated liver cirrhosis].
Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Murai K; Sadoshima S; Fujishima M; Ichiya Y
Fukuoka Igaku Zasshi; 1991 Oct; 82(10):521-7. PubMed ID: 1748367
[TBL] [Abstract][Full Text] [Related]
31. Hepatic microcirculation assessed by positron emission tomography of first-pass ammonia metabolism in porcine liver.
Keiding S; Munk OL; Vilstrup H; Nielsen DT; Roelsgaard K; Bass L
Liver Int; 2005 Feb; 25(1):171-6. PubMed ID: 15698415
[TBL] [Abstract][Full Text] [Related]
32. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
Albrecht J; Jones EA
J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392
[TBL] [Abstract][Full Text] [Related]
33. Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy.
Riggio O; Mannaioni G; Ridola L; Angeloni S; Merli M; Carlà V; Salvatori FM; Moroni F
Am J Gastroenterol; 2010 Jun; 105(6):1374-81. PubMed ID: 20125128
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology of hepatic encephalopathy: a new look at ammonia.
Butterworth RF
Metab Brain Dis; 2002 Dec; 17(4):221-7. PubMed ID: 12602499
[TBL] [Abstract][Full Text] [Related]
36. Dietary and nutritional indications in hepatic encephalopathy.
Merli M; Riggio O
Metab Brain Dis; 2009 Mar; 24(1):211-21. PubMed ID: 19052853
[TBL] [Abstract][Full Text] [Related]
37. The involvement of ammonia with the mechanisms that enhance GABA-ergic neurotransmission in hepatic failure.
Jones EA; Basile AS
Adv Exp Med Biol; 1997; 420():75-83. PubMed ID: 9286427
[No Abstract] [Full Text] [Related]
38. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia.
Lockwood AH; McDonald JM; Reiman RE; Gelbard AS; Laughlin JS; Duffy TE; Plum F
J Clin Invest; 1979 Mar; 63(3):449-60. PubMed ID: 429564
[TBL] [Abstract][Full Text] [Related]
39. Hepatobiliary transport kinetics of the conjugated bile acid tracer
Ørntoft NW; Munk OL; Frisch K; Ott P; Keiding S; Sørensen M
J Hepatol; 2017 Aug; 67(2):321-327. PubMed ID: 28249726
[TBL] [Abstract][Full Text] [Related]
40. Relation of taurine transport and brain edema in rats with simple hyperammonemia or liver failure.
Hilgier W; Olson JE; Albrecht J
J Neurosci Res; 1996 Jul; 45(1):69-74. PubMed ID: 8811513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
